Lymphoid malignancy as a presenting sign of ataxia-telangiectasia

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 5, 2000, Pages 464-467

  Loeb, David M ^a,b   Lederman, Howard M ^a   Winkelstein, Jerry A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Ataxia telangiectasia; Chemotherapy; Leukemia; Lymphoid malignancy; Lymphoma

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; CASE REPORT; GENETIC COUNSELING; GENETICS; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MALE; PRESCHOOL CHILD;

ATAXIA TELANGIECTASIA; CHILD, PRESCHOOL; GENETIC COUNSELING; HUMANS; INFANT; LEUKEMIA; LYMPHOMA; MALE;

EID: 0034265278     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200009000-00017     Document Type: Article

References (22)

1. McFarlin DE, Strober W, Waldmann TA. Ataxia-telangiectasia. Medicine (Baltimore) 1972; 51: 281-314.
2. Frizzera G, Rosai J, Dehner LP, Spector BD, Kersey JH. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer 1980; 46: 692-9.
3. Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 1998; 102: 98-100.
4. Waldmann TA, McIntire KR. Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet 1972; 2: 1112-5.
5. Jason JM, Gelfand EW. Diagnostic considerations in ataxia-telangiectasia. Arch Dis Child 1979; 54: 682-6.
6. Heppell A, Butterworth SV, Hollis RJ, Kennaugh AA, Beatty DW, Taylor AM. Breakage of the T cell receptor alpha chain locus in non-malignant clones from patients with ataxia telangiectasia. Hum Genet 1988; 79: 360-4.
7. Taylor AM, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975; 258: 427-9.
8. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 1986; 77: 89-92.
9. Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 3rd ed. Philadelphia: Lippincott-Raven, 1997;431-81.
10. Savitsky K, Sfez S, Tagle DA, et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995; 4: 2025-32.
11. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase [see comments]. Science 1995; 268: 1749-53.
12. Byrd PJ, McConville CM, Cooper P, et al. Mutations revealed by sequencing the 5 half of the gene for ataxia telangiectasia. Hum Mol Genet 1996; 5: 145-9.
13. Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15: 177-202.
14. Hartley KO, Gell D, Smith GC, et al. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 1995; 82: 849-56.
15. Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996; 86: 159-71.
16. Elson A, Wang Y, Daugherty CJ, et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci USA 1996; 93: 13084-9.
17. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma [see comments]. Genes Dev 1996; 10: 2411-22.
18. Stankovic T, Kidd AM, Sutcliffe A, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 1998; 62: 334-45.
19. Fiorilli M, Businco L, Pandolfi F, Paganelli R, Russo G, Aiuti F. Heterogeneity of immunological abnormalities in ataxia-telangiectasia. J Clin Immunol 1983; 3: 135-41.
20. Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 1998; 31: 491-7.
21. Draper GJ, Heaf MM, Kinnier Wilson LM. Occurrence of childhood cancers among sibs and estimation of familial risks. J Med Genet 1977; 14: 81-90.
22. de Laet C, Casimir G, Duchateau J, et al. Leukemia lymphoma T-cell as first manifestation of ataxia-telangiectasia. Arch Pediatr 1996; 3: 681-4.